Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114756) titled 'A randomized, double-blinded, placebo-controlled clinical trial of the efficacy and safety of SHR-0302 combine with Prednisone Acetate in the treatment of active arteritis' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhongshan hospital, Fudan University
Condition:
Takayasu arteritis
Intervention:
Experimental group:the combination of glucocorticoids and ivarmacitinib
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental group:29;Control group:29;
Countries of Recruitment:
China
To know more,...